In support of this, the downregulation of CD95 in cancer cells is reported to impair apoptosis and the efficient elimination of malignant cells, while it behaves like a growth factor receptor in cancer cells, which is ascribed to low stimulation strength [186,290,294,295]. Here, FAS is linked to cancer.